Editorials

Aya Allam, M.D., Steven Lippmann, M.D. Besides all the pandemic talk these days, we hear lots about coronavirus treatment with monoclonal antibodies. There are many of them. What is the big deal? Casirivimab and imdevimab are two monoclonal antibodies synthesized by the pharmaceutical company Regeneron, brand-named REGEN-COV. These dual proteins are a monoclonal antibodies intervention […]

Gurpreet Singh Guliani, M.D., Steven Lippmann, M.D. We have been hearing a lot about ivermectin these days. You too? Well, ivermectin has long been established as a veterinary medication to treat animals with many different types of parasitic infections; useful there, it has been around for a while without fanfare. Ivermectin is also approved for […]

Aya Allam, M.D., Steven Lippmann, M.D. Now in our second year of a coronavirus pandemic, the Food and Drug Administration (FDA) is approving COVID-19 vaccines. They are well researched, proven safe, currently effective, and already utilized by millions of people. Trust in the FDA as a medical authority enhances their recommendations for getting immunized. Similarly, […]

Shivam Gulati, M.D., Steven Lippmann, M.D. Introduction Post-COVID-19 syndrome includes illness presentations during or following an infection that persist longer than 12 weeks and not otherwise diagnosed (1).  Manifestation of this so-called “long-covid” can exist throughout the body, including the nervous system. Psychological aspects are often the first symptoms, sometimes even before recognizing COVID-19 disease. […]

Nivedita Jha, M.D., Steven Lippmann, M.D. Many people with COVID-19 infections evidence constitutional and/or respiratory concerns. Neurological, gastrointestinal, and/or cardiovascular presentations are less common. Stroke occurrences among people with COVID-19 illness include ischemic events, intracerebral hemorrhage, and cerebral venous thromboses (1). COVID-19 disproportionately affects certain groups (2). Patients with serious COVID-19 disease evidence an elevated […]

Gurpreet Singh Guliani, M.D., Steven Lippmann, M.D. Electronic cigarettes entered the US market in 2007 (1). They quickly gained popularity with e-cigarette use among an estimated 60,000 students in 2011, rising to about 570,000 by 2018 (2). E-cigarette devices have evolved with the latest ones called “pod mods”. They utilize a heating element at a […]

Steven Lippmann, M.D. Assuring good hydration is a goal for physicians. Proper fluid and electrolyte balance is vital. Yet, dehydration in selected clinical circumstances is beneficial and medically indicated, especially in near death terminal circumstances. Providing for comfort is important to all healthcare. And comfort care is the primary treatment plan for sick people near […]

Steven Lippmann, M.D. Aluminum and psychiatry? Aluminum is the third most common element in the earth. Dementia specialists and others have debated whether aluminum ingestion through the gastrointestinal track or skin is bad for brain health. Does it cause or facilitate cognitive decline or development of other neurologic disorders? The research is not conclusive. Some […]

Leo Sher, M.D. My commentary, “Post-COVID syndrome and suicide risk” was published in the QJM: An International Journal of Medicine online ahead of print on January 24, 2021 and included in the February 2021 print issue of the Journal (1). A summary of my article is below: A significant number of coronavirus disease SARS-CoV-2 (COVID-19) […]

Steven Lippmann, M.D. What about young people’s sports-related brain-health? What advice do we offer? Boxing has long been known to induce brain injury from frequent, powerful blows to the head. Serious neuropsychiatric and cognitive sequela occur over time and are recognized. Recurrent damage can result in chronic traumatic encephalopathies (CTE). Neuronal pathology is documented. Chronic […]